Ju Yup Lee1,2, Nayoung Kim1,3, Ryoung Hee Nam1, Soo In Choi1, Jung Won Lee4, Dong Ho Lee1,3. 1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoungnam, South Korea. 2. Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea. 3. Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea. 4. Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
Abstract
BACKGROUND: Antimicrobial resistance of Helicobacter pylori (H pylori) affects the efficacy of eradication therapy. The aim of this study was to estimate the prevalence of primary and secondary resistance of H pylori isolates to antibiotics in Korea. METHODS: The present study was performed from 2003 to 2018. Primary resistance was evaluated in 591 patients without any history of eradication and secondary resistance in 149 patients from whom Helicobacter pylori was cultured after failure of eradication. A minimal inhibitory concentration test was performed for amoxicillin, clarithromycin, metronidazole, tetracycline, levofloxacin, and rifabutin using the agar dilution method. RESULTS: An increase in the primary resistance rate was found in clarithromycin (P < .001), metronidazole (P < .001), and both levofloxacin (P < .001) during the study period. The primary resistance rates of amoxicillin and tetracycline were low and stable during the study period. The secondary resistance rate significantly increased in metronidazole and levofloxacin (P = .022 and .039, respectively). CONCLUSIONS: The primary and secondary resistance rates of clarithromycin, metronidazole, and levofloxacin for Helicobacter pylori in Korea were high and increased over time. However, the primary and secondary resistance rates of amoxicillin and tetracycline were low and stable over time. These results will help in selecting effective eradication regimens of H pylori in Korea in the future.
BACKGROUND: Antimicrobial resistance of Helicobacter pylori (H pylori) affects the efficacy of eradication therapy. The aim of this study was to estimate the prevalence of primary and secondary resistance of H pylori isolates to antibiotics in Korea. METHODS: The present study was performed from 2003 to 2018. Primary resistance was evaluated in 591 patients without any history of eradication and secondary resistance in 149 patients from whom Helicobacter pylori was cultured after failure of eradication. A minimal inhibitory concentration test was performed for amoxicillin, clarithromycin, metronidazole, tetracycline, levofloxacin, and rifabutin using the agar dilution method. RESULTS: An increase in the primary resistance rate was found in clarithromycin (P < .001), metronidazole (P < .001), and both levofloxacin (P < .001) during the study period. The primary resistance rates of amoxicillin and tetracycline were low and stable during the study period. The secondary resistance rate significantly increased in metronidazole and levofloxacin (P = .022 and .039, respectively). CONCLUSIONS: The primary and secondary resistance rates of clarithromycin, metronidazole, and levofloxacin for Helicobacter pylori in Korea were high and increased over time. However, the primary and secondary resistance rates of amoxicillin and tetracycline were low and stable over time. These results will help in selecting effective eradication regimens of H pylori in Korea in the future.
Authors: Young-Il Kim; Jong Yeul Lee; Chan Gyoo Kim; Boram Park; Jin Young Park; Il Ju Choi Journal: BMC Gastroenterol Date: 2021-03-02 Impact factor: 3.067
Authors: Chang Min Lee; Seong Je Kim; Se In Hah; Ji Yoon Kwak; Jung Woo Choi; Hyun Chin Cho; Chang Yoon Ha; Ok Jae Lee; Woon Tae Jung Journal: Health Sci Rep Date: 2022-08-23
Authors: Su Jin Kim; Sam Ryong Jee; Moo In Park; Kyoungwon Jung; Gwang Ha Kim; Moon Won Lee; Jin Lee; Jin Seok Jang; Myeongseok Koh Journal: Medicine (Baltimore) Date: 2022-08-19 Impact factor: 1.817